Author Question: One of the biggest differences between attending to current concerns and engaging in long-term ... (Read 23 times)

skymedlock

  • Hero Member
  • *****
  • Posts: 561
One of the biggest differences between attending to current concerns and engaging in long-term planning is that how people deal with current concerns is more dependent upon ____.
 
  a. intrinsic rewards rather than extrinsic rewards
  b. the cultural or social significance of things
  c. high levels of meaning
  d. practical constraints

Question 2

Much of the time, people engage in altruistic behaviors because doing so makes them feel good. Is it correct to conclude, then, that altruistic acts are fundamentally selfish at their core? What do social psychologists generally conclude?
 
  a. They are split on the issue.
  b. In general, they believe that genuine altruism DOES NOT exist.
  c. In general, they believe that genuine altruism DOES exist.
  d. In general, they believe that genuine altruism DOES existthough a small minority (mainly those working within evolutionary psychology) believe that it DOES NOT exist.



otokexnaru

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

D

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library